| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f834f5263ce989aee54251579a7bad57 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-34 |
| filingDate |
2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9856ba0ecb1763f41fbb4d3102e38e12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d6ca6cdfb8dca0f6c3993637313393d |
| publicationDate |
2016-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016039890-A1 |
| titleOfInvention |
Intraocular angiogenesis inhibitor and uses thereof |
| abstract |
Intended is to provide a new therapeutic or prophylactic means for intraocular angiogenesis. Provided is an intraocular angiogenesis inhibitor including a polypeptide which is a variant of diphtheria toxin, and shows activity inhibiting binding between HB-EGF and an EGF receptor. |
| priorityDate |
2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |